Tenascin-W is a better cancer biomarker than tenascin-C for most human solid tumors

Florence Brellier; Enrico Martina; Martin Degen; Nathalie Heuzé-Vourc’h; Agnès Petit; Thomas Kryza; Yves Courty; Luigi Terracciano; Christian Ruiz; Ruth Chiquet-Ehrismann

doi:10.1186/1472-6890-12-14

Download references

Tenascin-W is a better cancer biomarker than tenascin-C for most human solid tumors

Florence Brellier^†, Enrico Martina^†, Martin Degen, Nathalie Heuzé-Vourc’h, Agnès Petit, Thomas Kryza, Yves Courty, Luigi Terracciano, Christian Ruiz and Ruth Chiquet-Ehrismann^*

* Corresponding author: Ruth Chiquet-Ehrismann ruth.chiquet@fmi.ch
† Equal contributors

BMC Clinical Pathology 2012, 12:14 doi:10.1186/1472-6890-12-14

Include	Article citation and all cited references Cited references only Article citation only
Format	EndNote, Zotero or Papers Reference Manager Refworks BibTeX

BMC Clinical Pathology

Viewing options

Associated material

Tools

Share this article

Download references

Tenascin-W is a better cancer biomarker than tenascin-C for most human solid tumors

BMC Clinical Pathology

Viewing options

Associated material

Related literature

Cited by

Other articles by authors

Related articles/pages

Tools

Share this article

Download references

Tenascin-W is a better cancer biomarker than tenascin-C for most human solid tumors